Wichita, kan. (KWCH) -KOBACH KOBACH has announced today a national settlement of about $ 770 million with eight drug manufacturers that manufacture opioid pills and worsen the national opioid crisis.
Kansas will receive an agreement of about $ 5.7 million.
“We are responsible for human suffering caused by illegal marketing practices for many years,” said Kobach. “This dollar will help to save life because it is used to prevent and treat drug addiction throughout Kansas.”
To solve the Opioid Crisis as part of the transaction, the total amount of money to pay for the funds is as follows.
- MyLan (currently part of Viaatris): $ 284,447,916 paid for 9 years
- HIKMA: $ 95,818,293 paid over 1-4 years
- Yangbijang: $ 71,751,010 has been paid for 10 years
- Apotex: $ 63,682,369 in 1 year
- INDIVIOR: $ 38,022,450 has been paid over 4 years.
- Sun: $ 30,992,087 has been paid over 1-4 years.
- ALVOGEN: $ 18,680,162 in 1 year
- Zydus: $ 14,859,220 in 1 year
In addition to these reductions, some agreements are allowed to receive free pharmaceutical products or cash instead of this product.
In addition, seven companies (not containing indivior) cannot promote or market opioids and opioid products, and they cannot create or sell products containing more than 40 mg of oxicodon per pill, and have a monitoring and reporting system for suspicious orders.
INDIVIOR has agreed not to manufacture or sell Opioid products for the next 10 years, but we will continue to market and sell drugs to treat opioid use disorders.
Copyright 2025 kwch. All rights holdings. If you want to report modifications or typos, please send an email to news@kwch.com
